About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 617595, 8 pages
http://dx.doi.org/10.1155/2013/617595
Review Article

Thymic Regulatory T Cell Development: Role of Signalling Pathways and Transcription Factors

1Centre for Inflammatory Diseases, Monash Medical Centre, Southern Clinical School, Monash University, Clayton, VIC 3168, Australia
2Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia
3Department of Clinical Haematology, Central Clinical School, Melbourne, VIC 3000, Australia

Received 14 June 2013; Accepted 21 August 2013

Academic Editor: E. Shevach

Copyright © 2013 Mark Engel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Klein, M. Hinterberger, G. Wirnsberger, and B. Kyewski, “Antigen presentation in the thymus for positive selection and central tolerance induction,” Nature Reviews Immunology, vol. 9, no. 12, pp. 833–844, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Anderson and M. A. Su, “Aire and T cell development,” Current Opinion in Immunology, vol. 23, no. 2, pp. 198–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. Griesemer, E. C. Sorenson, and M. A. Hardy, “The role of the thymus in tolerance,” Transplantation, vol. 90, no. 5, pp. 465–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, “Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases,” Journal of Immunology, vol. 155, no. 3, pp. 1151–1164, 1995. View at Scopus
  5. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, “Regulatory T cells and immune tolerance,” Cell, vol. 133, no. 5, pp. 775–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Sakaguchi, K. Fukuma, K. Kuribayashi, and T. Masuda, “Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participiation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease,” Journal of Experimental Medicine, vol. 161, no. 1, pp. 72–87, 1985. View at Scopus
  7. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4+CD25+ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Khattri, T. Cox, S. A. Yasayko, and F. Ramsdell, “An essential role for Scurfin in CD4+CD25+ T regulatory cells,” Nature Immunology, vol. 4, no. 4, pp. 337–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Fontenot, J. L. Dooley, A. G. Farr, and A. Y. Rudensky, “Developmental regulation of Foxp3 expression during ontogeny,” Journal of Experimental Medicine, vol. 202, no. 7, pp. 901–906, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Shevach, T. S. Davidson, E. N. Huter, R. A. DiPaolo, and J. Andersson, “Role of TGF-β in the induction of Foxp3 expression and T regulatory cell function,” Journal of Clinical Immunology, vol. 28, no. 6, pp. 640–646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Apostolou, A. Sarukhan, L. Klein, and H. von Boehmer, “Origin of regulatory T cells with known specificity for antigen,” Nature Immunology, vol. 3, no. 8, pp. 756–763, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Jordan, A. Boesteanu, A. J. Reed et al., “Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide,” Nature Immunology, vol. 2, no. 4, pp. 301–306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Lerman, J. Larkin III, C. Cozzo, M. S. Jordan, and A. J. Caton, “CD4+ CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen,” Journal of Immunology, vol. 173, no. 1, pp. 236–244, 2004. View at Scopus
  15. J. Cabarrocas, C. Cassan, F. Magnusson et al., “Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 22, pp. 8453–8458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. W. J. Lio and C. S. Hsieh, “A two-step process for thymic regulatory T cell development,” Immunity, vol. 28, no. 1, pp. 100–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. W. J. Lio, L. F. Dodson, C. M. Deppong, C. S. Hsieh, and J. M. Green, “CD28 facilitates the generation of Foxp3-cytokine responsive regulatory T cell precursors,” Journal of Immunology, vol. 184, no. 11, pp. 6007–6013, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. K. B. Vang, J. Yang, A. J. Pagán et al., “Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoir,” Journal of Immunology, vol. 184, no. 8, pp. 4074–4077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Burchill, J. Yang, K. B. Vang et al., “Linked T Cell Receptor and Cytokine Signaling Govern the Development of the Regulatory T Cell Repertoire,” Immunity, vol. 28, no. 1, pp. 112–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Gerondakis, A. Banerjee, G. Grigoriadis et al., “NF-κB subunit specificity in hemopoiesis,” Immunological Reviews, vol. 246, no. 1, pp. 272–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Macian, “NFAT proteins: key regulators of T-cell development and function,” Nature Reviews Immunology, vol. 5, no. 6, pp. 472–484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. P. G. Hogan, L. Chen, J. Nardone, and A. Rao, “Transcriptional regulation by calcium, calcineurin, and NFAT,” Genes and Development, vol. 17, no. 18, pp. 2205–2232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Gupta, S. Manicassamy, C. Vasu, A. Kumar, W. Shang, and Z. Sun, “Differential requirement of PKC-θ in the development and function of natural regulatory T cells,” Molecular Immunology, vol. 46, no. 2, pp. 213–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Wu, M. Borde, V. Heissmeyer et al., “FOXP3 controls regulatory T cell function through cooperation with NFAT,” Cell, vol. 126, no. 2, pp. 375–387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Zeiser, V. H. Nguyen, A. Beilhack et al., “Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production,” Blood, vol. 108, no. 1, pp. 390–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Tone, K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone, “Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer,” Nature Immunology, vol. 9, no. 2, pp. 194–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Vaeth, U. Schliesser, G. Muller et al., “Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 40, pp. 16258–16263, 2012. View at Publisher · View at Google Scholar
  28. M. Oh-hora and A. rao, “The calcium/NFAT pathway: role in development and function of regulatory T cells,” Microbes and Infection, vol. 11, no. 5, pp. 612–619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Bopp, A. Palmetshofer, E. Serfling et al., “NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 181–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. O. F. Bueno, E. B. Brandt, M. E. Rothenberg, and J. D. Molkentin, “Defective T cell development and function in calcineurin Aβ-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 14, pp. 9398–9403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. E. M. Gallo, M. M. Winslow, K. Canté-Barrett et al., “Calcineurin sets the bandwidth for discrimination of signals during thymocyte development,” Nature, vol. 450, no. 7170, pp. 731–735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. Neilson, M. M. Winslow, E. M. Hur, and G. R. Crabtree, “Calcineurin B1 is essential for positive but not negative selection during thymocyte development,” Immunity, vol. 20, no. 3, pp. 255–266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. Li, A. Shakya, X. Guo et al., “Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity,” Journal of Immunology, vol. 188, no. 9, pp. 4268–4277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. B. D. Medoff, B. P. Sandall, A. Landry et al., “Differential requirement for CARMA1 in agonist-selected T-cell development,” European Journal of Immunology, vol. 39, no. 1, pp. 78–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. L. L. Molinero, J. Yang, T. Gajewski, C. Abraham, M. A. Farrar, and M. L. Alegre, “CARMA1 controls an early checkpoint in the thymic development of foxP3 + regulatory T cells,” Journal of Immunology, vol. 182, no. 11, pp. 6736–6743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Schmidt-Supprian, G. Courtois, J. Tian et al., “Mature T cells depend on signaling through the IKK complex,” Immunity, vol. 19, no. 3, pp. 377–389, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Schmidt-Supprian, J. Tian, E. P. Grant et al., “Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-κB activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4566–4571, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. O. Gaide, B. Favier, D. F. Legler et al., “CARMAI is a critical lipid raft-associated regulator of TCR-induced NF-κB activation,” Nature Immunology, vol. 3, no. 9, pp. 836–843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Jiang and X. Lin, “Regulation of NF-kappaB by the CARD proteins,” Immunological Reviews, vol. 246, no. 1, pp. 141–153, 2012. View at Publisher · View at Google Scholar
  40. D. Wang, Y. You, S. M. Case et al., “A requirement for CARMAI in TCR-induced NF-κB activation,” Nature Immunology, vol. 3, no. 9, pp. 830–835, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Lin and D. Wang, “The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling,” Seminars in Immunology, vol. 16, no. 6, pp. 429–435, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Sommer, B. Guo, J. L. Pomerantz et al., “Phosphorylation of the CARMA1 linker controls NF-κB activation,” Immunity, vol. 23, no. 6, pp. 561–574, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Wang, R. Matsumoto, Y. You et al., “CD3/CD28 costimulation-induced NF-κB activation is mediated by recruitment of protein kinase C-θ, Bcl10, and IκB kinase β to the immunological synapse through CARMA1,” Molecular and Cellular Biology, vol. 24, no. 1, pp. 164–171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Hoffmann, G. Natoli, and G. Ghosh, “Transcriptional regulation via the NF-κB signaling module,” Oncogene, vol. 25, no. 51, pp. 6706–6716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Scheidereit, “IκB kinase complexes: gateways to NF-κB activation and transcription,” Oncogene, vol. 25, no. 51, pp. 6685–6705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Oh and S. Ghosh, “NF-κB: roles and regulation in different CD4(+) T-cell subsets,” Immunological Reviews, vol. 252, no. 1, pp. 41–51, 2013. View at Publisher · View at Google Scholar
  47. I. Isomura, S. Palmer, R. J. Grumont et al., “c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells,” Journal of Experimental Medicine, vol. 206, no. 13, pp. 3001–3014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Long, S. G. Park, I. Strickland, M. S. Hayden, and S. Ghosh, “Nuclear factor-κB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor,” Immunity, vol. 31, no. 6, pp. 921–931, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. Ruan, V. Kameswaran, Y. Tone et al., “Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome,” Immunity, vol. 31, no. 6, pp. 932–940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Zheng, S. Josefowicz, A. Chaudhry, X. P. Peng, K. Forbush, and A. Y. Rudensky, “Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate,” Nature, vol. 463, no. 7282, pp. 808–812, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. E. K. Deenick, A. R. Elford, M. Pellegrini, H. Hall, T. W. Mak, and P. S. Ohashi, “c-Rel but not NF-κB1 is important for T regulatory cell development,” European Journal of Immunology, vol. 40, no. 3, pp. 677–681, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Grigoriadis, A. Vasanthakumar, A. Banerjee et al., “C-rel controls multiple discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells,” PLoS ONE, vol. 6, no. 10, Article ID e26851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. A. J. Lee, X. Wu, H. Cheng, X. Zhou, X. Cheng, and S. C. Sun, “CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling,” Journal of Biological Chemistry, vol. 285, no. 21, pp. 15696–15703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Rao, S. Gerondakis, D. Woltring, and M. F. Shannon, “c-Rel is required for chromatin remodeling across the IL-2 gene promoter,” Journal of Immunology, vol. 170, no. 7, pp. 3724–3731, 2003. View at Scopus
  55. X. Tai, M. Cowan, L. Feigenbaum, and A. Singer, “CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2,” Nature Immunology, vol. 6, no. 2, pp. 152–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Bour-Jordan and J. A. Bluestone, “Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells,” Immunological Reviews, vol. 229, no. 1, pp. 41–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Salomon, D. J. Lenschow, L. Rhee et al., “B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes,” Immunity, vol. 12, no. 4, pp. 431–440, 2000. View at Scopus
  58. Q. Tang, K. J. Henriksen, E. K. Boden et al., “Cutting edge: CD28 controls peripheral homeostasis of CD4 +CD25+ regulatory T cells,” Journal of Immunology, vol. 171, no. 7, pp. 3348–3352, 2003. View at Scopus
  59. L. H. Boise, A. J. Minn, P. J. Noel et al., “CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-x(L),” Immunity, vol. 3, no. 1, pp. 87–98, 1995. View at Scopus
  60. J. S. Burr, N. D. L. Savage, G. E. Messah et al., “Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL,” Journal of Immunology, vol. 166, no. 9, pp. 5331–5335, 2001. View at Scopus
  61. R. M. Thomas, L. Gao, and A. D. Wells, “Signals from CD28 induce stable epigenetic modification of the IL-2 promoter,” Journal of Immunology, vol. 174, no. 8, pp. 4639–4646, 2005. View at Scopus
  62. C. Nazarov-Stoica, J. Surls, C. Bona, S. Casares, and T. D. Brumeanu, “CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message,” Journal of Immunology, vol. 182, no. 1, pp. 102–110, 2009. View at Scopus
  63. J. D. Fontenot, J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky, “A function for interleukin 2 in Foxp3-expressing regulatory T cells,” Nature Immunology, vol. 6, no. 11, pp. 1142–1151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. L. M. D'Cruz and L. Klein, “Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling,” Nature Immunology, vol. 6, no. 11, pp. 1152–1159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. C. L. Bennett, J. Christie, F. Ramsdell et al., “The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3,” Nature Genetics, vol. 27, no. 1, pp. 20–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. B. R. Powell, N. R. M. Buist, and P. Stenzel, “An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy,” Journal of Pediatrics, vol. 100, no. 5, pp. 731–737, 1982. View at Scopus
  67. R. S. Wildin, F. Ramsdell, J. Peake et al., “X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy,” Nature Genetics, vol. 27, no. 1, pp. 18–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. M. E. Brunkow, E. W. Jeffery, K. A. Hjerrild et al., “Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse,” Nature Genetics, vol. 27, no. 1, pp. 68–73, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. V. L. Godfrey, J. E. Wilkinson, and L. B. Russell, “X-linked lymphoreticular disease in the scurfy (sf) mutant mouse,” American Journal of Pathology, vol. 138, no. 6, pp. 1379–1387, 1991. View at Scopus
  70. H. P. Kim and W. J. Leonard, “CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation,” Journal of Experimental Medicine, vol. 204, no. 7, pp. 1543–1551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. Z. Yao, Y. Kanno, M. Kerenyi et al., “Nonredundant roles for Stat5a/b in directly regulating Foxp,” Blood, vol. 109, no. 10, pp. 4368–4375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Zorn, E. A. Nelson, M. Mohseni et al., “IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo,” Blood, vol. 108, no. 5, pp. 1571–1579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. M. A. Burchill, J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar, “IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells,” Journal of Immunology, vol. 178, no. 1, pp. 280–290, 2007. View at Scopus
  74. G. Lal, N. Zhang, W. Van Der Touw et al., “Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation,” Journal of Immunology, vol. 182, no. 1, pp. 259–273, 2009. View at Scopus
  75. S. Floess, J. Freyer, C. Siewert et al., “Epigenetic control of the foxp3 locus in regulatory T cells,” PLoS Biology, vol. 5, no. 2, article e38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Toker and J. Huehn, “To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms,” Science Signaling, vol. 4, no. 158, article pe4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. B. Liu, S. Tahk, K. M. Yee, G. Fan, and K. Shuai, “The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression,” Science, vol. 330, no. 6003, pp. 521–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. W. Ouyang, O. Beckett, Q. Ma, J. H. Paik, R. A. Depinho, and M. O. Li, “Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells,” Nature Immunology, vol. 11, no. 7, pp. 618–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. L. F. Lu, T. H. Thai, D. P. Calado et al., “Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein,” Immunity, vol. 30, no. 1, pp. 80–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Kohlhaas, O. A. Garden, C. Scudamore, M. Turner, K. Okkenhaug, and E. Vigorito, “Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells1,” Journal of Immunology, vol. 182, no. 5, pp. 2578–2582, 2009. View at Publisher · View at Google Scholar · View at Scopus